Nasal spray shows promise in combating Alzheimer's

ANSA

Center

Factuality

Ownership

Università Cattolica, the drug 'turns off' an enzyme in the brain (ANSA)

News Medical

Center

Factuality

Ownership

Nasal spray shows promise in combating Alzheimer's

A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that by inhibiting the brain enzyme S-acyltransferase (zDHHC) through a nasal-spray drug, they can counteract the cognitive decline and brain damage typical of the disease.

Il Fatto Quotidiano

Lean Left

Factuality

Ownership

Another step in understanding Alzheimer's and perhaps in the future a weapon to stem the disease that affects 55 million people worldwide and about 600 thousand in Italy. Researchers at the Gemelli Catholic University-Policlinico in Rome have succeeded in blocking cognitive decline and brain damage in animals with the disease, administering them a nasal spray based on an experimental drug that 'turns off' an enzyme (S-acyltransferase or ZdHHC) i…

24matins.fr

Factuality

Ownership

The potential of a nasal spray to delay the onset of Alzheimer's disease is revealed in a new study.

Stirile Pro TV

Stirile Antena 1 Observator

View article

Reposted by

Stirile Antena 1 Observator

Factuality

Ownership

A future treatment for Alzheimer's disease could involve something as simple as a nasal spray. Scientists have found that by nasal spray they can inhibit an enzyme and prevent the cognitive decline and brain damage typical of the disease.

Scientific Inquirer

Factuality

Ownership

Alzheimer’s: A new strategy to prevent neurodegeneration - Scientific Inquirer

A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that by inhibiting the brain enzyme S-acyltransferase (zDHHC) through a nasal-spray drug, they can counteract the cognitive decline and brain damage typical of the disease. The study has been led by Professor Claudio Grassi, Director of the Neuroscience Department, and P…